메뉴 건너뛰기




Volumn 65, Issue 5, 2011, Pages 1064-1065

Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; HYDROCORTISONE; PARACETAMOL; PREDNISOLONE; RITUXIMAB;

EID: 80054098371     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.06.033     Document Type: Article
Times cited : (32)

References (5)
  • 2
    • 34548056791 scopus 로고    scopus 로고
    • Treatment of severe pemphigus with rituximab: Report of 12 cases and a review of the literature
    • G. Cianchini, R. Corona, A. Frezzolini, M. Ruffelli, B. Didona, and P. Puddu Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature Arch Dermatol 143 2007 1033 1038
    • (2007) Arch Dermatol , vol.143 , pp. 1033-1038
    • Cianchini, G.1    Corona, R.2    Frezzolini, A.3    Ruffelli, M.4    Didona, B.5    Puddu, P.6
  • 4
    • 33750291236 scopus 로고    scopus 로고
    • Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
    • A.R. Ahmed, Z. Spigelman, L.A. Cavacini, and M.R. Posner Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin N Engl J Med 355 2006 17
    • (2006) N Engl J Med , vol.355 , pp. 17
    • Ahmed, A.R.1    Spigelman, Z.2    Cavacini, L.A.3    Posner, M.R.4
  • 5
    • 33646095268 scopus 로고    scopus 로고
    • Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed
    • A.S. Belgi, M. Azeez, C. Hoyle, and R.E. Williams Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed Clin Exp Dermatol 31 2006 143
    • (2006) Clin Exp Dermatol , vol.31 , pp. 143
    • Belgi, A.S.1    Azeez, M.2    Hoyle, C.3    Williams, R.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.